(1)
Erfan, G.; Puig, S.; Carrera, C.; Arance, A.; Gaba, L.; Victoria, I.; Garcia-Herrera, A.; Alos, L.; Malvehy, J. Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination With MEK Inhibitors. Acta Derm Venereol 2016, 97, 258-260.